In another blow to the London Stock Exchange, Cheshire-based Redx Pharma announced it plans to de-list from AIM and re-register as a private limited company. Redx chair…

Shares of Alderley Park-based Redx Pharma rose about 12% as the clinical-stage biotechnology company announced that three abstracts submitted by the firm “have been accepted…

Shares of Alderley Park-based Redx Pharma rose about 20% after it announced that Dublin-based Jazz Pharmaceuticals plc will acquire Redx’s KRAS (Kirsten rat sarcoma virus)…

Shares of Alderley Park-based Redx Pharma rose as much as 20% after it announced that zelasudil (RXC007), an oral, selective Rho Associated Coiled-Coil Containing Protein…

Alderley Park-based Redx Pharma announced it made a loss of £20.8 million for the six months ended March 31, 2023, “driven by lower revenue, higher…

By Mark McSherry Shares of Alderley Park-based Redx Pharma fell about 15% on Monday after it announced that its $425 million all-share merger agreement with…

By Mark McSherry Alderley Park-based Redx Pharma and Massachusetts-based Jounce Therapeutics have announced a “unanimously recommended business combination” of the two companies via a proposed all…

Shares of Alderley Park-based Redx Pharma rose as much as 8% after it announced it entered into a clinical trial collaboration and supply agreement with MSD…

Shares of Alderley Park-based Redx Pharma rose about 5% on Wednesday after the US Food and Drug Administration (FDA) cleared the investigational new drug (IND)…

Alderley Park-based Redx Pharma, the drug development company focused on cancer and fibrosis, announced it conditionally raised £34.2 million via a placing sale of 58 million…

Alderley Park-based Redx Pharma, the drug development company focused on cancer and fibrosis, announced that its revenue rose about 75% to £10 million in the…

Shares of Alderley Park-based drug discovery Redx Pharma rose about 15% on Thursday after it announced a milestone payment from AstraZeneca has been triggered as a…

Alderley Park-based Redx Pharma, the drug discovery and development company focused on oncology and fibrosis, announced the appointment of Jane Griffiths as its non-executive chair,…

Shares of Macclesfield-based Redx Pharma plc rose about 7% on Thursday after it announced that a milestone payment from AstraZeneca has been triggered “as a…

Macclesfield-based Redx Pharma plc, the drug development company focused on cancer and fibrosis, announced that Iain Ross is stepping down from his role as director and…

Macclesfield-based Redx Pharma plc, the drug development company focused on cancer and fibrosis, announced it appointed Peter Collum as chief financial officer (CFO). Collum will…

Shares of Macclesfield-based Redx Pharma plc rose 4% on Wednesday after the drug company focused on cancer and fibrosis announced that it “successfully initiated dosing…

Shares of Macclesfield-based Redx Pharma plc rose as much as 10% on Wednesday after it published financial results for the year ended September 30, 2020,…

Shares of Macclesfield-based Redx Pharma plc rose another 15% on Wednesday after it announced a new research collaboration with Dublin-based Jazz Pharmaceuticals to discover and…

Shares of Macclesfield-based Redx Pharma plc soared about 160% on Tuesday after it announced a “significant out licensing agreement for its porcupine inhibitor, RXC006” with…